TABLE 1.
Author | Age | Clinical information | Site (testis) | HL subtype | IHC | Stage | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|
Our case | 40 | Cervical, mediastinal, abdominal mass, testicular involvement(relapse) | Bilateral | MC | CD15 (+) | IVB | CT (6xABVD) | CR (DFS 1 years) |
Ben Ameur El Youbi and Errihani (3) | 17 | Cervical mass, Empty scrotum (initial involvement) | Left | NS | CD15 (+) | |||
CD30 (+) | IVB | Orchiectomy + CT (8xABVD) | CR (DFS 2 years) | |||||
Gatt et al. (1) | 73 | Testicular mass (initial involvement) | Right | NS | CD3 (+) | IVA | Orchiectomy (Not taken CT) | Died before CT |
CD15 (+) | ||||||||
CD30 (+) | ||||||||
Seliem et al. (2) | 52 | Testicular mass (initial involvement) | Left | Classical | CD15 (+) | IVB | Orchiectomy + CT(4xABVD and 2xAVD) | CR (Not reached) |
CD30 (+) | ||||||||
Glaholm et al. (4) | 56 | Scrotal pain (initial involvement), Axillary node | Right | MC | np | IVA | Orchiectomy + CT (6xChlVPP) | CR (DFS 3 years) |
Vishniavsky et al. (5) | 79 | Inguinal mass (initial involvement) | Right | Hodgkin sarcoma (autopsy) | np | - | - | Died before treatment |
HL: Hodgkin’s lymphoma; IHC: immunohistochemistry; NS: nodular sclerosis; MC: mixed cellularity; np: not performed; CT: chemotherapy; ABVD: doxorubicin, bleomycin, vinblastine, dacarbazine; AVD: doxorubicin, vinblastine, dacarbazine; ChlVPP : chlorambucil, vinblastine procarbazine, prednisolone; CR: complete response; DFS: disease free survival.